---
title: "Xintian Pharma: Expected net profit in the first half of 2025 to decrease by 83.52% - 76.93% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248397255.md"
description: "Xintian Pharma expects its net profit in the first half of 2025 to decrease by 83.52% year-on-year to 76.93 million yuan, with the net profit attributable to shareholders of the listed company expected to be between 5 million yuan and 7 million yuan. The net profit after deducting non-recurring gains and losses is expected to be between 3 million yuan and 4.2 million yuan, with basic earnings per share expected to be between 0.0205 yuan and 0.0287 yuan"
datetime: "2025-07-14T10:14:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248397255.md)
  - [en](https://longbridge.com/en/news/248397255.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248397255.md)
generator: "portal-rs"
---

# Xintian Pharma: Expected net profit in the first half of 2025 to decrease by 83.52% - 76.93% year-on-year

Xintian Pharma announced that it expects the net profit attributable to shareholders of the listed company for the period from January 1, 2025, to June 30, 2025, to be between 5 million and 7 million yuan, a decrease of 83.52% to 76.93% compared to the same period last year, which was 30.3395 million yuan. The net profit after deducting non-recurring gains and losses is expected to be between 3 million and 4.2 million yuan, a decrease of 89.83% to 85.77% compared to the same period last year, which was 29.513 million yuan. The basic earnings per share are expected to be between 0.0205 yuan/share and 0.0287 yuan/share, a decrease compared to the same period last year's 0.1312 yuan/share

### Related Stocks

- [002873.CN](https://longbridge.com/en/quote/002873.CN.md)

## Related News & Research

- [Vector Science files US provisional patent for orthopedic tissue-regeneration peptide platform](https://longbridge.com/en/news/296483037.md)
- [LEAD Launch Leaves Accountable Care Technology Buyers Little Time for a Wrong Decision, Q3 Study](https://longbridge.com/en/news/296106866.md)
- [01:33 ETMagIron Demonstrates Excellent Direct Reduction Pellet Quality in Latest Test Program](https://longbridge.com/en/news/296439181.md)
- [JIC Venture Growth Investments takes minority stake in rocket engine startup Letara](https://longbridge.com/en/news/296418219.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**